Cost-utility analysis of a telehealth psychological support intervention for people with primary brain tumor: Telehealth Making Sense of brain tumor.

Gordon, LG; Jones, S; Parker, G; Chambers, S; Aitken, JF; Foote, M; Shum, DHK; Robertson, J; Conlon, E; Pinkham, MB; Ownsworth, T

Cost-utility analysis of a telehealth psychological support intervention for people with primary brain tumor: Telehealth Making Sense of brain tumor.

Gordon, LG Jones, S Parker, G Chambers, S

Aitken, JF Foote, M Shum, DHK Robertson, J Conlon, E Pinkham, MB Ownsworth, T

Permalink

Publisher:: WILEY
Publication Type:: Journal Article
Citation:: Psycho-oncology, 2024, 33, (1), pp. e6243
Issue Date:: 2024-01

Closed Access

	Filename	Description	Size
	Psycho-Oncology - 2023 - Gordon - Cost‐utility analysis of a telehealth psychological support intervention for people with.pdf	Published version	1.26 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Gordon, LG
dc.contributor.author	Jones, S
dc.contributor.author	Parker, G
dc.contributor.author	Chambers, S https://orcid.org/0000-0003-2369-6111
dc.contributor.author	Aitken, JF
dc.contributor.author	Foote, M
dc.contributor.author	Shum, DHK
dc.contributor.author	Robertson, J
dc.contributor.author	Conlon, E
dc.contributor.author	Pinkham, MB
dc.contributor.author	Ownsworth, T
dc.date.accessioned	2024-09-23T04:27:06Z
dc.date.available	2023-10-25
dc.date.available	2024-09-23T04:27:06Z
dc.date.issued	2024-01
dc.identifier.citation	Psycho-oncology, 2024, 33, (1), pp. e6243
dc.identifier.issn	1057-9249
dc.identifier.issn	1099-1611
dc.identifier.uri	http://hdl.handle.net/10453/180921
dc.description.abstract	OBJECTIVE: To undertake an economic evaluation of a telehealth psychological support intervention for patients with primary brain tumor (PBT). METHODS: A within-trial cost-utility analysis over 6 months was performed comparing a tailored telehealth-psychological support intervention with standard care (SC) in a randomized control trial. Data were sourced from the Telehealth Making Sense of Brain Tumor (Tele-MAST) trial survey data, project records, and administrative healthcare claims. Quality-adjusted life years (QALYs) were calculated based on the EuroQol-5D-5L. Non-parametric bootstrapping with 2000 iterations was used to determine sampling uncertainty. Multiple imputation was used for handling missing data. RESULTS: The Tele-MAST trial included 82 participants and was conducted in Queensland, Australia during 2018-2021. When all healthcare claims were included, the incremental cost savings from Tele-MAST were -AU$4,327 (95% CI: -$8637, -$18) while incremental QALY gains were small at 0.03 (95% CI: -0.02, 0.08). The likelihood of Tele-MAST being cost-effective versus SC was 87% at a willingness-to-pay threshold of AU$50,000 per QALY gain. When psychological-related healthcare costs were included only, the incremental cost per QALY gain was AU$10,685 (95% CI: dominant, $24,566) and net monetary benefits were AU$534 (95% CI: $466, $602) with a 65% likelihood of the intervention being cost-effective. CONCLUSIONS: Based on this small randomized controlled trial, the Tele-MAST intervention is a cost-effective intervention for improving the quality of life of people with PBT in Australia. Patients receiving the intervention incurred significantly lower overall healthcare costs than patients in SC. There was no significant difference in costs incurred for psychological health services.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	WILEY
dc.relation	http://purl.org/au-research/grants/nhmrc/1152217
dc.relation.ispartof	Psychooncology
dc.relation.isbasedon	10.1002/pon.6243
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences, 1112 Oncology and Carcinogenesis, 1701 Psychology
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.classification	32 Biomedical and clinical sciences
dc.subject.classification	52 Psychology
dc.subject.mesh	Humans
dc.subject.mesh	Cost-Benefit Analysis
dc.subject.mesh	Quality of Life
dc.subject.mesh	Telemedicine
dc.subject.mesh	Health Care Costs
dc.subject.mesh	Brain Neoplasms
dc.subject.mesh	Quality-Adjusted Life Years
dc.subject.mesh	Humans
dc.subject.mesh	Brain Neoplasms
dc.subject.mesh	Telemedicine
dc.subject.mesh	Quality-Adjusted Life Years
dc.subject.mesh	Quality of Life
dc.subject.mesh	Cost-Benefit Analysis
dc.subject.mesh	Health Care Costs
dc.subject.mesh	Humans
dc.subject.mesh	Cost-Benefit Analysis
dc.subject.mesh	Quality of Life
dc.subject.mesh	Telemedicine
dc.subject.mesh	Health Care Costs
dc.subject.mesh	Brain Neoplasms
dc.subject.mesh	Quality-Adjusted Life Years
dc.title	Cost-utility analysis of a telehealth psychological support intervention for people with primary brain tumor: Telehealth Making Sense of brain tumor.
dc.type	Journal Article
utslib.citation.volume	33
utslib.location.activity	England
utslib.for	1103 Clinical Sciences
utslib.for	1112 Oncology and Carcinogenesis
utslib.for	1701 Psychology
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
dc.date.updated	2024-09-23T04:27:04Z
pubs.issue	1
pubs.publication-status	Published
pubs.volume	33
utslib.citation.issue	1

Abstract:

OBJECTIVE: To undertake an economic evaluation of a telehealth psychological support intervention for patients with primary brain tumor (PBT). METHODS: A within-trial cost-utility analysis over 6 months was performed comparing a tailored telehealth-psychological support intervention with standard care (SC) in a randomized control trial. Data were sourced from the Telehealth Making Sense of Brain Tumor (Tele-MAST) trial survey data, project records, and administrative healthcare claims. Quality-adjusted life years (QALYs) were calculated based on the EuroQol-5D-5L. Non-parametric bootstrapping with 2000 iterations was used to determine sampling uncertainty. Multiple imputation was used for handling missing data. RESULTS: The Tele-MAST trial included 82 participants and was conducted in Queensland, Australia during 2018-2021. When all healthcare claims were included, the incremental cost savings from Tele-MAST were -AU$4,327 (95% CI: -$8637, -$18) while incremental QALY gains were small at 0.03 (95% CI: -0.02, 0.08). The likelihood of Tele-MAST being cost-effective versus SC was 87% at a willingness-to-pay threshold of AU$50,000 per QALY gain. When psychological-related healthcare costs were included only, the incremental cost per QALY gain was AU$10,685 (95% CI: dominant, $24,566) and net monetary benefits were AU$534 (95% CI: $466, $602) with a 65% likelihood of the intervention being cost-effective. CONCLUSIONS: Based on this small randomized controlled trial, the Tele-MAST intervention is a cost-effective intervention for improving the quality of life of people with PBT in Australia. Patients receiving the intervention incurred significantly lower overall healthcare costs than patients in SC. There was no significant difference in costs incurred for psychological health services.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/180921